DBD
NYSE
US
Diebold Nixdorf Incorporated Common stock
$84,34
▼ $-0,48
(-0,57%)
Vol 12K
Kap. Pasar
$3.0B
P/E
31,5
ROE
8,8%
Margin
2,5%
Beta
-51,09
52W
$36–$86
Konsensus Wall Street
7 analis · Apr 20262
Beli Kuat
4
Beli
1
Tahan
0
Jual
0
Jual Kuat
85,7%
Peringkat Beli
Grafik Harga
Saham Serupa
SMCI
Super Micro Computer Inc
P/E 22,0
$17.5B
IONQ
IONQ Inc
$10.6B
GPGI
GPGI Inc
$4.7B
INFQ
Infleqtion Inc
$2.7B
QUBT
Quantum Computing Inc
$2.3B
KODK
Eastman Kodak Co
$1.2B
CRSR
Corsair Gaming Inc
$633.1M
OSS
One Stop Systems Inc
$176.0M
TBCH
Turtle Beach Corp
P/E 14,8
$270.9M
AAPL
Apple Inc
P/E 35,9
$4.0T
Pendapatan
Tingkat beat: 100,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $1,64 | $2,75 | +$1,11 |
| Sep 2025 | $0,94 | $1,38 | +$0,44 |
| Jun 2025 | $0,59 | $0,94 | +$0,35 |
| Mar 2025 | $0,36 | $0,37 | +$0,01 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $988.9M | $841.1M | $915.2M | $945.2M | $1.1B |
| Laba Bersih | — | $5.6M | -$8.3M | $12.2M | $41.1M | $49.6M |
Rasio Utama
ROA (TTM)
2,5%
P/S (TTM)
0,78
P/B
2,2
EPS (TTM)
$2,58
CF/Share
$-5,84
Pertumbuhan Pendapatan 3T
+3,2%
52W High
$85,99
52W Low
$36,43
$36,43
Rentang 52 Minggu
$85,99
Kesehatan Keuangan
Arus Kas Bebas
$195.7M
Utang Bersih
$569.6M
Kas
$368.9M
Total Utang
$938.5M
Per tanggal Des 31, 2025
Як DBD виглядає на тлі конкурентів у Technology?
Група порівняння: Peers · Technology (Peers) · 10 компаній
Оцінка DBD vs аналоги Technology
P/E
31,5
▲
43%
di atas
rekan
(22,0)
vs Rekan
vs Industri
Lebih mahal
P/S
0,8
▼
64%
di bawah
rekan
(2,2)
vs Rekan
vs Industri
Undervalued
P/B
2,2
▼
78%
di bawah
rekan
(9,9)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(1,2%)
vs Rekan
vs Industri
Sejajar
Прибутковість DBD vs аналоги Technology
ROE
8,8%
▼
17%
di bawah
rekan
(10,6%)
vs Rekan
vs Industri
Lemah
Net margin
2,5%
▼
20%
di bawah
rekan
(3,1%)
vs Rekan
vs Industri
Lemah
Валова маржа
26,4%
▼
16%
di bawah
rekan
(31,4%)
vs Rekan
vs Industri
Lemah
ROA
2,5%
▲
0%
di atas
rekan
(2,5%)
vs Rekan
vs Industri
Sejajar
Фінансове здоровʼя DBD vs аналоги Technology
D/E ratio
—
▼
0%
di bawah
rekan
(103,5)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
1,3
▼
42%
di bawah
rekan
(2,2)
vs Rekan
vs Industri
Likuiditas rendah
Beta
-51,1
▼
4187%
di bawah
rekan
(1,3)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів DBD
DBD
Median rekan
Industri
DBD прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
DBD vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
7
Penjualan
0
BAUR FRANK TOBIAS
Chief Operating Officer · Feb 27
award
7589 shs
RADIGAN ELIZABETH CHRISTINE
Officer · Feb 27
award
6607 shs
ZOSEL ANDREW JOSEPH
Chief Technology Officer · Feb 27
award
6561 shs
TIMKO THOMAS S.
Chief Financial Officer · Feb 27
award
15308 shs
SESPLANKIS JEFFREY M
Officer · Feb 27
award
2215 shs
MARQUEZ OCTAVIO
Chief Executive Officer · Feb 27
award
44286 shs
MYERS JONATHAN
Officer · Feb 27
award
9448 shs
Terakhir 90 hari
Imbal Hasil Beli Orang Dalam
BAUR FRANK TOBIAS
Mei 09, 2025
$32284
+82,87%
Pemegang Terbesar
Top 5: 66,5%Capital World Investors
33,26%
$981.7M
Millstreet Capital Manageme…
16,42%
$484.7M
Blackrock Inc.
6,01%
$177.2M
Vanguard Group Inc
5,63%
$166.1M
William Blair Investment Ma…
5,18%
$152.8M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait